Prestige Consumer Healthcare (PBH) Cash & Equivalents Growth (1y) (2011 - 2026)
Prestige Consumer Healthcare (PBH) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 69.13% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 2.86% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 19.56% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 13.19% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 56.51% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 25.91% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | -1.67% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | -4.65% |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | - | -34.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.75% |
| Dec 31, 2025 | 22.60% |
| Sep 30, 2025 | 131.09% |
| Jun 30, 2025 | 307.23% |
| Mar 31, 2025 | 110.64% |
| Dec 31, 2024 | -20.03% |
| Sep 30, 2024 | -14.20% |
| Jun 30, 2024 | -37.24% |
| Mar 31, 2024 | -20.55% |
| Dec 31, 2023 | -26.34% |
| Sep 30, 2023 | 41.53% |
| Jun 30, 2023 | 52.16% |
| Mar 31, 2023 | 115.15% |
| Dec 31, 2022 | 310.88% |
| Sep 30, 2022 | -0.88% |
| Jun 30, 2022 | -78.08% |
| Mar 31, 2022 | -15.84% |
| Dec 31, 2021 | -66.16% |
| Sep 30, 2021 | 60.95% |
| Jun 30, 2021 | 182.40% |